Seminars in Oncology
Volume 36, Supplement 1 , Pages S36-S41, April 2009

Cell Culture Modeling of Genotype-Directed Sensitivity to Selective Kinase Inhibitors: Targeting the Anaplastic Lymphoma Kinase (ALK)

  • Jeff Settleman

      Affiliations

    • Corresponding Author InformationAddress correspondence to Jeff Settleman, PhD, Center for Molecular Therapeutics, Massachusetts General Hospital Cancer Center and Harvard Medical School, 149 13th St, Charlestown, MA 02129

Center for Molecular Therapeutics, Massachusetts General Hospital Cancer Center and Harvard Medical School, Charlestown, MA

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 STATEMENT OF CONFLICT OF INTEREST: Dr Settleman has served as a consultant to Cephalon Oncology.

PII: S0093-7754(09)00034-7

doi:10.1053/j.seminoncol.2009.02.006

Seminars in Oncology
Volume 36, Supplement 1 , Pages S36-S41, April 2009

Article Tools